The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

It is also indicated for regional analgesia in adults via an interscalene brachial plexus nerve block, sciatic nerve block in the popliteal fossa and femoral nerve block in the adductor canal.

Commitment to Efficiency and Margin Expansion. The Pacira Board and management team are committed to enhancing the company’s operational efficiency and expect to prioritize opportunities to drive ...

Pacira has three commercial-stage non-opioid treatments: Exparel (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting of inducement awards on April 2, 2025 to 18 new ...

today announced a new strategic partnership with open-source compliance and security platform provider FOSSA Inc. and introduced a product integration that allows organizations to eliminate ...

Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

Furthermore, color-enhanced Doppler ultrasonography also helps distinguish an aneurysm from a popliteal mass, such as a Baker's cyst. [20] Still further, preoperative duplex mapping of the ...

and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular ...